Programme - Infectious diseases: Challenges, threats and responsibilities

Session I
	North-South: the political economy of affliction Chair: Rainer Sauerborn, Medical Faculty, Heidelberg University, Germany
	Infections and Inequalities: examples from Haiti and Peru Paul Farmer, Harvard Medical School, Cambridge, USA
	New challenges for research partnerships to alleviate disease burden and poverty Marcel Tanner, Director, Swiss Tropical Institute, Basel, Switzerland
	The embodiment of inequality: political anthropology of AIDS in southern Africa Didier Fassin, School for Advanced Studies in Social Sciences (EHESS), University of Paris North/Inserm, France
	Neglected diseases, underfunded research, poor health interventions: can we change this reality? Carlos Morel, Tropical Disease Research, WHO, Geneva, Switzerland

Session II
	The big killers: past, present and future Chair: Michel Glauser, Medical Faculty, University of Lausanne, Switzerland
	HIV and AIDS Robin A. Weiss, University College, London, UK
	The economic divide: politics, research and control of TB in the developing world Paul van Helden, Stellenbosch University Tygerberg, South Africa
	Past problems and future opportunities for malaria and dengue control Janet Hemingway, Liverpool School of Tropical Medicine, Liverpool, UK
	The gaps: wealth, life expectancy, public health infrastructure and the big global killers Laurie Garrett, writer and journalist, Newsday, New York, USA
	Panel discussion Johannes Sommerfeld, Chair, Social, Economic and Behavioural Research, WHO-TDR, Geneva, Switzerland Ruth M. Ruprecht, Harvard Medical School, Cambridge, USA Rachel Snow, Department of Tropical Hygiene and Public Health, Heidelberg University, Germany Yeya T. Touré, TDR, WHO, Geneva, Switzerland Hermann Bujard, Centre for Molecular Biology, Heidelberg University, Germany

Session III:
	Consequences and responses Chair: Hans-Georg Kraeusslich, Medical Faculty, Heidelberg University, Germany
	The barriers to the production of new antibiotics Peter N. Goodfellow, GlaxoSmithKline Pharmaceuticals, Essex, UK
	Knowledge: a prime weapon of defense against infectious diseases Helena Maekelae, National Public Health Institute, Helsinki, Finland
	Responding to unmet medical and control needs: past experiences and future opportunities Robert Ridley, Product Research and Development, TDR, WHO, Geneva, Switzerland
	Infectious disease control in China: shift from public domination to the public and private partnership Yiming Shao, National Center for AIDS Prevention and Control, Beijing, China
	Panel discussion Denise P. Barlow, Chair, Institute for Molecular Biology, Salzburg, Austria Michael Boutros, Harvard Medical School, Cambridge, USA Arachu Castro, Harvard Medical School, Cambridge, USA Patricia Kahn, International AIDS Vaccine Initiative Helen Epstein, independent writer Giuseppe Testa, Biotec-Dresden Technical University (TUD)

Session IV
	Biological weapons: uses and abuses of infectious agents Chair: Friedrich Frischknecht, Laboratoire de Biologie et Genetique du Paludisme, Institut Pasteur, Paris, France
	Advances in science and technology: risks, perspectives and responsibilities Volker Beck, Advisor to the German Foreign Office, Berlin, Germany
	The role of the 'Biological and Toxin Weapons Convention' in combating infectious disease John Walker, Arms Control and Disarmament Research Unit, Foreign and Commonwealth Office, London, UK
	Bioweapons and genetic engineering: the dual-use problem in the biomedical sciences Jan van Aken, Sunshine Projekts, Hamburg, Germany